Weill Cornell Medicine, Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Comprehensive Weight Control Center, New York, NY 10065, USA.
Weill Cornell Medical College, New York, NY 10065, USA.
J Diabetes Complications. 2021 Aug;35(8):107967. doi: 10.1016/j.jdiacomp.2021.107967. Epub 2021 May 28.
To explore predictors of severe COVID-19 disease in patients with diabetes hospitalized for COVID-19.
This is a retrospective observational study of adults with diabetes admitted for COVID-19. Bivariate tests and multivariable Cox regression were used to identify risk factors for severe COVID-19, defined as a composite endpoint of intensive care unit admission/intubation or in-hospital death.
In 1134 patients with diabetes admitted for COVID-19, more severe disease was associated with older age (HR 1.02, p<0.001), male sex (HR 1.28, p=0.017), Asian race (HR 1.34, p=0.029 [reference: white]), and greater obesity (moderate obesity HR 1.59, p=0.015; severe obesity HR 2.07, p=0.002 [reference: normal body mass index]). Outpatient diabetes medications were not associated with outcomes.
Age, male sex, Asian race, and obesity were associated with increased risk of severe COVID-19 disease in adults with type 2 diabetes hospitalized for COVID-19.
In patients with type 2 diabetes hospitalized for COVID-19 disease, we observed that age, male sex, Asian race, and obesity predicted severe COVID-19 outcomes of intensive care unit admission, intubation, or in-hospital death. The risk conferred by obesity increased with worsening obesity. Outpatient diabetes medications were not observed to be significant predictors of study outcomes.
探讨因 COVID-19 住院的糖尿病患者发生重症 COVID-19 的预测因素。
这是一项回顾性观察性研究,纳入因 COVID-19 住院的成年糖尿病患者。采用单变量检验和多变量 Cox 回归分析来确定重症 COVID-19 的危险因素,重症 COVID-19 的定义为入住重症监护病房/插管或院内死亡的复合终点。
在 1134 例因 COVID-19 住院的糖尿病患者中,更严重的疾病与年龄较大(HR 1.02,p<0.001)、男性(HR 1.28,p=0.017)、亚洲人种(HR 1.34,p=0.029[参照:白人])和更高的肥胖程度(中度肥胖 HR 1.59,p=0.015;重度肥胖 HR 2.07,p=0.002[参照:正常体重指数])相关。门诊糖尿病药物与结局无关。
年龄、男性、亚洲人种和肥胖与 2 型糖尿病成年患者因 COVID-19 住院发生重症 COVID-19 的风险增加相关。
在因 COVID-19 住院的 2 型糖尿病患者中,我们观察到年龄、男性、亚洲人种和肥胖预测了入住重症监护病房、插管或院内死亡的重症 COVID-19 结局。肥胖的风险随着肥胖程度的恶化而增加。门诊糖尿病药物不是研究结局的显著预测因素。